Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Pomalidomide, Cyclophosphamide and Dexamethasone (PCd): Outcomes in Patients With Double- or Triple-Refractory Multiple Myeloma.
Authors: Hidalgo-Soto M; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain., Rodríguez-Lobato LG; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain., Motlló Borrella C; Haematology Department, Hospital Parc Taulí, Sabadell, Spain., Sánchez Cayuela Á; Haematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Lopez Pardo J; Haematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Rosiñol L; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain., Cibeira MT; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain., García-Guiñon A; Haematology Department, Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain., Tolosa-Ridao C; Haematology Department, Hospital Universitari MútuaTerrassa, Terrassa, Spain., Carro Arostegui I; Haematology Department, Institut Català D'oncologia (ICO) Bellvitge, Institut D'investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain., Sureda A; Haematology Department, Institut Català D'oncologia (ICO) Bellvitge, Institut D'investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain., Herranz MJ; Haematology Department, Hospital Santa Tecla, Tarragona, Spain., Abella Montreal E; Haematology Department, Hospital del Mar, Barcelona, Spain., Pelicano M; Haematology Department, Hospital Sant Joan de Déu - Fundació Althaia, Manresa, Spain., Barrau Alzuria Y; Haematology Department, Institut Català D'oncologia (ICO) Tarragona, Tarragona, Spain., Cortes Sansa M; Haematology Department, Hospital Sant Joan de Déu - Fundació Althaia, Manresa, Spain., Gironella M; Haematology Department, Hospital Universitari Vall D'hebron, Barcelona, Spain., González Y; Haematology Department, Institut Català D'oncologia (ICO), Girona, Spain., Fernández De Larrea C; Haematology Department, Instituto de Investigaciones Biomédicas August pi i Sunyer (IDIBAPS), Barcelona, Spain.; Haematology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
Source: European journal of haematology [Eur J Haematol] 2026 Jun; Vol. 116 (6), pp. 806-815. Date of Electronic Publication: 2026 Feb 06.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1600-0609
DOI:10.1111/ejh.70126